Tigermed Reports 2022 Interim Result with Strong Financial Growth

Adella Miesner

HANGZHOU, China, Aug. 25, 2022 /PRNewswire/ — Hangzhou Tigermed Consulting Co., Ltd. (“Tigermed” or the “company”) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its interim results for the first half of 2022, ended June 30, […]

Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results

Adella Miesner

Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 15, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, […]